Related Experiment Video
Updated: Jul 14, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Founder mutations in BRCA1 and BRCA2 genes
1Department of Surgery and Oncology, Regional Reference Center for the Biomolecular Characterization and Genetic Screening of Hereditary Tumors, Università di Palermo, Palermo.
Founder mutations in BRCA1 and BRCA2 genes significantly impact hereditary breast and ovarian cancers. Identifying these specific mutations in diverse populations aids genetic counseling and testing for high-risk families.
Area of Science:
- Genetics
- Oncology
- Population Genetics
Background:
- Germline mutations in BRCA1 and BRCA2 are key contributors to hereditary breast and ovarian cancers.
- The prevalence of these mutations varies significantly across different populations.
- Founder mutations, specific mutations occurring at high frequency in certain populations due to a founder effect, are common in BRCA1 and BRCA2.
Purpose of the Study:
- To review significant examples of BRCA gene founder mutations in European and non-European populations.
- To highlight the importance of identifying ethnic background in genetic counseling for hereditary cancer syndromes.
- To discuss how founder mutations can simplify genetic testing and inform penetrance studies.
Main Methods:
- Literature review of well-known BRCA1 and BRCA2 founder mutations.
- Haplotype analysis to distinguish the origin and age of high-frequency founder mutations.
- Examination of population-specific mutation frequencies.
Main Results:
- Specific BRCA1 and BRCA2 mutations are found with high frequency in various populations due to founder effects.
- Haplotype comparisons can elucidate the evolutionary history of these founder mutations.
- Documented examples of significant founder mutations across diverse ethnic groups are presented.
Conclusions:
- Identifying a family's ethnic group is crucial for targeted genetic counseling and testing strategies in hereditary breast and ovarian cancer.
- Founder mutations simplify genetic testing and facilitate large-scale studies to accurately determine mutation penetrance.
- Understanding population-specific mutation patterns improves the clinical management of hereditary cancer risk.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

